SCHOTT Pharma AG & Co. KGaA

XTRA:1SXP Stock Report

Market Cap: €4.5b

SCHOTT Pharma KGaA Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenure1.5yrs

Recent management updates

No updates

Recent updates

SCHOTT Pharma AG & Co. KGaA Beat Analyst Estimates: See What The Consensus Is Forecasting For Next Year

Sep 01
SCHOTT Pharma AG & Co. KGaA Beat Analyst Estimates: See What The Consensus Is Forecasting For Next Year

Is There An Opportunity With SCHOTT Pharma AG & Co. KGaA's (ETR:1SXP) 31% Undervaluation?

Aug 07
Is There An Opportunity With SCHOTT Pharma AG & Co. KGaA's (ETR:1SXP) 31% Undervaluation?

Earnings Miss: SCHOTT Pharma AG & Co. KGaA Missed EPS By 18% And Analysts Are Revising Their Forecasts

Jul 01
Earnings Miss: SCHOTT Pharma AG & Co. KGaA Missed EPS By 18% And Analysts Are Revising Their Forecasts

We Think SCHOTT Pharma KGaA (ETR:1SXP) Can Stay On Top Of Its Debt

Jun 07
We Think SCHOTT Pharma KGaA (ETR:1SXP) Can Stay On Top Of Its Debt

Calculating The Intrinsic Value Of SCHOTT Pharma AG & Co. KGaA (ETR:1SXP)

Mar 28
Calculating The Intrinsic Value Of SCHOTT Pharma AG & Co. KGaA (ETR:1SXP)

CEO

SCHOTT Pharma KGaA has no CEO, or we have no data on them.


Board Members

NamePositionTenureCompensationOwnership
Peter Goldschmidt
Independent Chairman of Supervisory Board1.5yrsno datano data
Wolfgang Wienand
Independent Vice Chairman of Supervisory Board1.5yrsno datano data
Eva Kienle
Independent Member of Supervisory Board1.5yrsno datano data
Ann-Kristin Erkens
Independent Member of Supervisory Board1.5yrsno datano data
Mario Just
Employee Representative Member of Supervisory Board1.5yrsno datano data
Christine Wening
Employee Representative Member of Supervisory Board1.5yrsno datano data

1.5yrs

Average Tenure

54.5yo

Average Age

Experienced Board: 1SXP's board of directors are not considered experienced ( 1.5 years average tenure), which suggests a new board.